The mean age at the time of MEN2A diagnosis was significantly different between patients with or without MTC (38.45 ± 16.30 versus 19.33 ± 15.71 years; t = 3.43, P = 0.001; Table 1, Fig. 2a). This evidence concerns the gene RET and medullary thyroid gland carcinoma.